- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Placebo insulin degludec
Total 56326 results
-
Oramed, Ltd.CompletedDiabetes Mellitus, Type 2United States
-
Centre Hospitalier Universitaire VaudoisUnknownMyocardial InfarctionSwitzerland
-
SanofiCompletedDiabetes Mellitus, Insulin-DependentUnited States
-
Oramed, Ltd.IntegriumTerminatedT2DM (Type 2 Diabetes Mellitus)United States
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1China
-
Northwestern UniversityCompletedHyperglycemia | Rejection | Evidence of Liver TransplantationUnited States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Israel, Poland, United Kingdom, Denmark, Spain, France, Austria, Norway, Russian Federation, Canada, Croatia, Argentina, South Africa, Australia, Ireland, Brazil, Finland
-
Amsterdam UMC, location VUmcCompleted
-
Bronx Veterans Medical Research Foundation, IncBoston University; VA Boston Healthcare SystemUnknownChronic Multisymptom Illness in Gulf War VeteransUnited States
-
Lise TarnowNovo Nordisk A/SCompleted
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited Kingdom, France
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, Austria, South Africa
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Sweden, Finland, France, Norway
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSlovenia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
University of GiessenSanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, Russian Federation, Denmark, Sweden, Macedonia, The Former Yugoslav Republic of, Norway, Croatia, France, Belgium, Slovakia
-
Emory UniversityCompletedHyperglycemiaUnited States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Australia
-
SanofiCompletedDiabetes Mellitus, Type 1France
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, United Kingdom, France, Netherlands, Finland, Germany, Sweden
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Japan
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesRomania
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada
-
Steno Diabetes Center CopenhagenCompletedDiabetes Mellitus, Type 2Denmark
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Canada, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Denmark, Spain, Norway, Italy, France, Netherlands
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2 | Acute Myocardial InfarctionCanada, Croatia, Czech Republic, Germany, Hungary, India, Israel, Lebanon, Poland, Romania, Russian Federation, Slovakia, Slovenia, South Africa, Spain, Turkey, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United Kingdom, Germany, Austria, Denmark, Norway, Sweden, Switzerland, Finland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Healthy VolunteersGermany
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United Kingdom, Denmark, Sweden, Netherlands, Belgium, Finland, France, Australia, Ireland, Norway
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Japan
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Japan
-
Tehran University of Medical SciencesCompletedType 2 Diabetes MellitusIran, Islamic Republic of
-
Novo Nordisk A/SCompleted
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentCompletedType 2 Diabetic Patients | Insufficient Metabolic Control | OAD TreatmentGermany
-
SanofiCompletedDiabetes Mellitus, Type 2Australia, United Kingdom
-
Imperial College LondonTerminated
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Russian Federation, Israel, Croatia, Czech Republic, Slovenia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany